Clearpoint Other Operating Expenses from 2010 to 2025

CLPT Stock  USD 14.21  3.01  17.48%   
Clearpoint Neuro Other Operating Expenses yearly trend continues to be comparatively stable with very little volatility. Other Operating Expenses is likely to outpace its year average in 2025. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2011-06-30
Previous Quarter
12.6 M
Current Value
13.3 M
Quarterly Volatility
3.3 M
 
Yuan Drop
 
Covid
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 330 K or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 17.19. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Latest Clearpoint Neuro's Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Clearpoint Neuro over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Clearpoint Neuro. It is also known as Clearpoint Neuro overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Clearpoint Neuro's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
15.819.029.736.946.451.153.720%56%24%26%10%5%
       Timeline  

Clearpoint Other Operating Expenses Regression Statistics

Arithmetic Mean22,344,257
Geometric Mean18,226,948
Coefficient Of Variation70.91
Mean Deviation13,258,064
Median13,715,362
Standard Deviation15,845,289
Sample Variance251.1T
Range45.5M
R-Value0.88
Mean Square Error60.5T
R-Squared0.78
Slope2,929,976
Total Sum of Squares3766.1T

Clearpoint Other Operating Expenses History

202553.7 M
202451.1 M
202346.4 M
202236.9 M
202129.7 M
202019 M
201915.8 M

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Operating Expenses51.1 M53.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.

Trending Assets

TELA
Tela Bio
2.52  -0.08  -3.08 
SWAV
Shockwave Medical
0.00  0.00  0.00 
LUNG
Pulmonx Corp
8.62  -0.6  -6.51 
NPCE
Neuropace
13.48  -0.36  -2.6 
RCEL
Avita Medical
8.90  -0.72  -7.48 
OSA
ProSomnus, Common Stock
0.00  0.00  0.00 
INGN
Inogen Inc
7.95  -0.16  -1.97 
TBIO
Telesis Bio
0.00  0.00  0.00 
INSP
Inspire Medical Systems
184.02  -12.59  -6.4 
NARI
Inari Medical
79.97  0.00  0.00 
OM
Outset Medical
0.73  -0.03  -3.95 
TMCI
Treace Medical Concepts
9.13  -0.57  -5.88 
CTSO
Cytosorbents Crp
1.07  -0.03  -2.73 
KIDS
Orthopediatrics Corp
23.00  0.05  0.22 
ELMD
Electromed
26.83  -0.63  -2.29 
SRDX
SurModics
35.90  0.36  1.01 
LIVN
LivaNova PLC
41.45  -0.25  -0.6 
SGHT
Sight Sciences
2.64  -0.17  -6.05 
APYX
Apyx Medical
1.38  -0.05  -3.5 
News Freq…Investor S…